ED
FLS icon

Exane Derivatives’s Flowserve FLS Stock Holding History

Exane Derivatives’s Portfolio FLS Stock Details FLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-1
Closed -$46 – 598
2017
Q2 		$46 Hold
1
– – ﹤0.01% 592
2017
Q1 		$48 Sell
1
-1
-50% -$48 ﹤0.01% 517
2016
Q4 		$96 Hold
2
– – ﹤0.01% 547
2016
Q3 		$96 Hold
2
– – ﹤0.01% 534
2016
Q2 		$90 Sell
2
-139
-99% -$6.51K ﹤0.01% 471
2016
Q1 		$6.26K Sell
141
-54
-28% -$2.23K ﹤0.01% 436
2015
Q4 		$8.2K Hold
195
– – ﹤0.01% 343
2015
Q3 		$8.02K Sell
195
-26
-12% -$1.19K ﹤0.01% 358
2015
Q2 		$11.6K Sell
221
-558
-72% -$31.1K ﹤0.01% 360
2015
Q1 		$44K Sell
779
-1,889
-71% -$110K ﹤0.01% 320
2014
Q4 		$160K Buy
+2,668
New +$170K 0.02% 240

Other funds holding FLS

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Causeway Capital Management Los Angeles, California $8.15B AUM 29.28% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Exane Derivatives's FLS Position: Q3 2017 in Review

Exane Derivatives sold out of Flowserve (FLS) in Q3 2017, closing a stake of 1 share — an estimated $46 sold.

Exane Derivatives first reported a position in FLS in Q4 2014 and held it in 11 quarters. The position peaked at $160K in Q4 2014. 374 funds tracked by Wall St. Rank hold FLS as of Q3 2017.

  • Exane Derivatives reported no remaining Flowserve position as of Q3 2017 after selling out during the quarter.
  • Exane Derivatives sold 1 Flowserve share in Q3 2017, an estimated $46.
  • Exane Derivatives first reported a position in Flowserve in Q4 2014 and held it in 11 quarters.
  • Exane Derivatives's Flowserve position peaked at $160K in Q4 2014.
  • 374 funds tracked by Wall St. Rank held Flowserve as of Q3 2017.

Based on Exane Derivatives's 13F filing for Q3 2017, filed 18 Oct 2017.